Navigation Links
E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research
Date:7/21/2014

ALBANY, New York, July 21, 2014 /PRNewswire/ --


According to a new market report published by Transparency Market Research "E-Clinical Solution Software Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020," the global microfluidic device market was valued at USD 3,005 million in 2014 and is expected to grow at a CAGR of 13.8% from 2014 to 2020, to reach an estimated value of USD 6,515.3 million in 2020.

Browse the full E-Clinical Solution Software Market Report with TOC at http://www.transparencymarketresearch.com/e-clinical-solution-software-market.html

Globally, the e-clinical solution software market is witnessing significant growth due to increasing clinical trials and R&D investments in pharmaceuticals and life science. Increasing prevalence of diseases supports clinical trials in different regions. Various lifestyle associated diseases and genetic disorders in the Middle East and North African countries have also enhanced clinical trials in the respective regions. In addition, the pharmaceutical industry is facing immense pressure to reduce the time consumed during clinical trials and to raise the productivity of drugs. Presence of various end users such as pharmaceuticals, clinical research organizations (CRO) and healthcare providers has increased the acceptance of e-clinical solution software. The global e-clinical solution software market is estimated at USD 3,005 million in 2014. It is likely to grow at a CAGR of 13.8% from 2014 to 2020 to reach USD 6,515.3 million in 2020.

North America is a traditional clinical trial region. The average cost of pharmaceutical research and development for a successful drug continues to increase from pre-clinical stage i.e. initial development stage of drug till FDA approval i.e. drug is launched in market. According to Oracle Corporation, an e-clinical software company, the percentage share of global clinical trials conducted in North America has reduced from 30% in 2006 to 19% in 2010. This was due to regulatory and legal considerations, which shifted the clinical trial market from North America to developing countries such as India and China. This may lead to sluggish growth of clinical trials in the region.

In Europe, Countries in Central and Eastern Europe provide abundant opportunities to life science companies for clinical development. According to Oracle Corporation, the percentage of clinical trials conducted in Western Europe has decreased from 25% to 19% and in Eastern Europe, the percentage has increased from 10% to 13% during 2006-2010. Similarly, according to the U.S. National Institutes of Health (Clinical Trial government registry), the clinical trials conducted in Europe were 46,192 in May 2014.

However, Asia has become one of the fastest-growing markets for pharmaceutical products. Improved industry regulatory laws and patent expiration laws in various countries including Japan, China and India, have led to the expansion of the clinical trials market in Asia. Asia has lower cost of conducting clinical trials compared to Europe or the U.S.

Related & Recently Published Reports by Transparency Market Research 


Oracle Corporation, Medidata Solutions, PAREXEL International Corporation, BioClinica, OmniComm Systems and others are the major players of e-clinical solution software market.

The e-clinical solution software market is segmented as follows:

E-Clinical Solution Software Market, By Mode of Delivery 

  • Web based e-clinical solution software
  • Licensed Enterprise e-clinical solution software
  • Cloud based e-clinical solution software

E-Clinical Solution Software Market, By Products 

  • Clinical Data Management
  • Clinical Trial Management System
  • Electronic Clinical Outcome Assessment Solution
  • Randomization and Trial Supply Management
  • Safety Solution

E-Clinical Solution Software Market, By End Users 

  • Pharmaceutical
  • Clinical Research Organizations
  • Healthcare Providers

Browse the full E-Clinical Solution Software Market Report with TOC at http://www.transparencymarketresearch.com/e-clinical-solution-software-market.html

E-Clinical Solution Software Market, by Geography 

  • North America
    • U.S.
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Poland
    • Russia
  • Asia
    • China
    • South Korea
    • Taiwan
    • India
  • Rest of the World (Row)

Browse All Pharmaceutical Market Research Reports @ http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About Us  

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Ms. Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
Company Blog: http://www.tmrblog.com/
Blog: http://transparencymarketresearch.areavoices.com/



'/>"/>
SOURCE www.transparencymarketresearch.com
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Global E-Clinical Trial Technologies Industry
2. Significant Pre-Clinical Data in Acute Lung Injury
3. New Pre-Clinical and Clinical Data on GeNO LLCs Nitric Oxide Delivery Systems to Be Presented at 2013 American College of Cardiology and American Thoracic Society Medical Meetings
4. ImmunGene and Collaborators Report Positive Results in Pre-clinical Studies of Novel Anti-CD20 Antibody-Interferon Alpha Fusion Protein
5. BioLineRx Announces Publication of Positive Pre-Clinical Results for BL-8040 in Treatment of Thrombocytopenia
6. Regulus Announces Significant Progress in Strategic Alliance with AstraZeneca and Selection of a New Pre-Clinically Validated microRNA Oncology Target
7. Epizyme, Inc. to Present Pre-Clinical Data on DOT1L and EZH2 Inhibitor Programs at the 55th ASH Annual Meeting
8. Pharmacovigilance Market [Clinical Trial Phases (Pre-Clinical Studies, Phase I, Phase II, Phase III, Phase IV or Post-Marketing Surveillance) and Service Providers (In-House and Contract Outsourcing] - Global Industry Analysis, Size, Share, Growth,
9. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
10. SolutionStart Corp. Announces John Karagiannis as Vice President of Technology
11. Stereotaxis Epochâ„¢ Solutions Momentum Drives Strong Presence at the Heart Rhythm Society (HRS) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... , July 24, 2017  Diplomat Pharmacy, Inc. ... will release its second quarter 2017 operating results on ... conference call to follow at 5:00 p.m. ET. ... may listen to a live broadcast of the conference ... and referencing participant code 51641230 approximately 15 minutes prior ...
(Date:7/20/2017)... July 20, 2017  Prime Therapeutics LLC (Prime) released this ... M.D., following today,s Institute for Clinical and Economic Review,s (ICER) ... the effectiveness and value of abuse-deterrent formulations (ADF) of opioids. ... roundtable at the meeting. ... cost benefit to the use of abuse-deterrent formulations (ADF) in ...
(Date:7/14/2017)... 2017 It should come as no surprise to ... in the midst of a crippling opioid epidemic. According to ... number of overdose deaths from opiate-based medications has quadrupled, Says, ... million dead from 2001 to 2015". During this time, the ... similarly quadrupled, drawing a compelling link between prescription and eventual ...
Breaking Medicine Technology:
(Date:7/24/2017)... ... 2017 , ... The International Essential Tremor Foundation (IETF) will host a free ... The seminar will take place on Saturday, Aug. 26 at the Embassy Suites by ... run from 9 a.m. to 12 p.m., with check-in beginning at 8 a.m. The ...
(Date:7/24/2017)... ... 2017 , ... Axiad IDS , a leading provider of trusted identities ... WALLIX to expand its solution to help government contractors more quickly and cost-effectively ... ways to address the authentication requirements within NIST SP800-171, but no matter how ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... that already work hand-in-hand on an Innovation Collaboration program, have signed a five-year ... experience and cost of the care members and patients receive. The agreement also ...
(Date:7/24/2017)... ... July 24, 2017 , ... Puregraft, the global ... the issuance of United States Patent Number 9,695,398 (the '398 patent) and South ... The '398 and '324 patents cover methods and systems for optimizing fat grafts ...
(Date:7/24/2017)... ... 24, 2017 , ... The 2017 NCSL International Workshop & ... focuses on the new ISO/IEC 17025 standards. This marks the first time in ... calibration will be changed. , As an exhibitor, METTLER TOLEDO will showcase ...
Breaking Medicine News(10 mins):